Nurix Therapeutics has announced its key objectives and anticipated milestones for the year 2024. The company is expected to provide updates on its progress and achievements throughout the year, which may include clinical trial results, regulatory filings, partnerships, or other significant developments. Investors will be closely monitoring Nurix's progress towards these goals as they can have a substantial impact on the company's performance and stock valuation.